Highlights Sanofi

Equities

SAN

FR0000120578

Pharmaceuticals

Market Closed - Euronext Paris Other stock markets 10:25:00 13/03/2026 pm IST			5-day change	1st Jan Change
76.39 ^EUR	-0.17%		0.00%	-7.65%

11/03	Brazil drugmaker EMS eyes overseas deals after buying Sanofi unit	RE
09/03	Global drugmakers rush to boost US presence as tariff threat looms	RE

Highlights

11/03	Brazil drugmaker EMS eyes overseas deals after buying Sanofi unit	RE
06/03	Brazil's EMS purchases Sanofi's Medley in deal worth over $500 million	RE
06/03	Brazil's EMS purchases Sanofi's Medley	RE
06/03	EMS S.A. announced the signing of a definitive agreement to acquire Sanofi Medley Farmacêutica Ltda. from Sanofi.	CI
05/03	Merck Outlook Disappoints – MS Drug Patent Loss Weighs on Forecast	RE
05/03	Germany's Merck KGaA Expects Currency Headwinds to Weigh on Earnings	DJ
04/03	Euroapi
03/03	Euroapi S.A. Provides Earnings Guidance for the Fy 2026	CI
02/03	Roche Multiple Sclerosis Drug Meets Main Goal in Late-Stage Trial -- Update	DJ
02/03	Sanofi Says Rilzabrutinib Receives Orphan Drug Status in Japan	MT
02/03	Sanofi's Rilzabrutinib Receives Orphan Designation in Japan	MT
02/03	Sanofi: rilzabrutinib earns orphan drug designation in Japan for IgG4-related disease	RE
28/02	Blueprint Medicines Announces Four-Year Pioneer Data Showing Sustained Benefit and Long-Term Safety of Ayvakit (Avapritinib) in Indolent Systemic Mastocytosis	CI
27/02	European Stocks Mostly Higher in Friday Trading; French GDP Growth Slows, Inflation Rises	MT
27/02	Sanofi and Regeneron's Dupixent Recommends for EU Approval to Treat Chronic Separate Urticaria in Young Children with Ongoing Symptoms Despite Treatment	CI
27/02	Regeneron Pharmaceuticals, Inc. and Sanofi Announce Positive CHMP Opinion for Dupixent in Treating Chronic Spontaneous Urticaria in Children Aged 2 to 11 Years	CI
27/02	Sanofi, Regeneron Win EU Panel's Positive Opinion for Skin Disease Treatment in Young Children	MT
27/02	Sanofi and DNDi Announces the European Medicines Agency's Committee for Medicinal Products for Human Use Grants Positive Opinion to Acoziborole Winthrop (Acoziborole) as A Single-Dose Oral Treatment	CI
27/02	Sanofi says Dupixent was recommended for EU approval to treat CSU in children	RE
27/02	EU regulator backs approval for Moderna's combined COVID and flu vaccine	RE
27/02	Sanofi's Sleeping Sickness Treatment Recommended for EU Approval	MT
27/02	Sanofi: Acoziborole Winthrop receives CHMP positive opinion	RE
27/02	Novavax raises revenue forecast on boost from vaccine deals, shares soar	RE
27/02	Novavax raises 2026 adjusted revenue outlook on strength in vaccine deals	RE
26/02	Novavax raises revenue forecast on boost from vaccine deals, shares soar	RE